Cardio Diagnostics Holdings, Inc. Financing Cash Flow
Cardio Diagnostics Holdings, Inc. (CDIO) reported Financing Cash Flow of $3.49 million for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-07.
Financial Statements › Cash Flow › Financing Activities
us-gaap:NetCashProvidedByUsedInFinancingActivities · last filed 2026-08-07
- Cardio Diagnostics Holdings, Inc. net cash provided by (used in) financing activities for the quarter ending 2026-06-30 was -$101.17K.
- Cardio Diagnostics Holdings, Inc. net cash provided by (used in) financing activities for the quarter ending 2026-03-31 was $3.59M, a 8.57% increase year-over-year.
- Cardio Diagnostics Holdings, Inc. net cash provided by (used in) financing activities for the quarter ending 2025-12-31 was $195.62K, a 97.32% decline year-over-year.
- Cardio Diagnostics Holdings, Inc. net cash provided by (used in) financing activities for the quarter ending 2025-09-30 was $39.95K, a 97.91% decline year-over-year.
- Cardio Diagnostics Holdings, Inc. net cash provided by (used in) financing activities for fiscal 2025 was $3.43M, a 71.28% decline from fiscal 2024.
- Cardio Diagnostics Holdings, Inc. net cash provided by (used in) financing activities for fiscal 2024 was $11.94M, a 228.74% increase from fiscal 2023.
- Cardio Diagnostics Holdings, Inc. net cash provided by (used in) financing activities for fiscal 2023 was $3.63M, a 59.92% decline from fiscal 2022.
- Cardio Diagnostics Holdings, Inc. net cash provided by (used in) financing activities for fiscal 2022 was $9.06M, a 639.90% increase from fiscal 2021.
| Period end | Net Cash Provided by (Used in) Financing Activities 1 month | Net Cash Provided by (Used in) Financing Activities 3 month | Net Cash Provided by (Used in) Financing Activities 4 month | Net Cash Provided by (Used in) Financing Activities 6 month | Net Cash Provided by (Used in) Financing Activities 6 month as first filed | Net Cash Provided by (Used in) Financing Activities 7 month | Net Cash Provided by (Used in) Financing Activities 9 month | Net Cash Provided by (Used in) Financing Activities 9 month as first filed | Net Cash Provided by (Used in) Financing Activities 12 month |
|---|---|---|---|---|---|---|---|---|---|
| 2026-06-30 | -$101.17K derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-07 | $3.49M 10-Q · filed 2026-08-07 | $3.69M derived: sum of 3 quarters · filed 2026-08-07 | $3.73M derived: sum of 4 quarters · filed 2026-08-07 | |||||
| 2026-03-31 | $3.59M 10-Q · filed 2026-05-15 | $3.79M derived: sum of 2 quarters · filed 2026-05-15 | $3.83M derived: sum of 3 quarters · filed 2026-05-15 | $3.71M derived: sum of 4 quarters · filed 2026-08-07 | |||||
| 2025-12-31 | $195.62K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-13 | $235.57K derived: sum of 2 quarters · filed 2026-03-13 | $120.54K derived: sum of 3 quarters · filed 2026-08-07 | $3.43M 10-K · filed 2026-03-13 | |||||
| 2025-09-30 | $39.95K derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-12 | -$75.08K derived: sum of 2 quarters · filed 2026-08-07 | $3.23M 10-Q · filed 2025-11-12 | $10.53M derived: sum of 4 quarters · filed 2026-08-07 | |||||
| 2025-06-30 | -$115.04K derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-07 | $3.19M 10-Q · filed 2026-08-07 | $10.49M derived: sum of 3 quarters · filed 2026-08-07 | $12.39M derived: sum of 4 quarters · filed 2026-08-07 | |||||
| 2025-03-31 | $3.31M 10-Q · filed 2026-05-15 | $10.60M derived: sum of 2 quarters · filed 2026-05-15 | $12.51M derived: sum of 3 quarters · filed 2026-05-15 | $13.67M derived: sum of 4 quarters · filed 2026-05-15 | |||||
| 2024-12-31 | $7.29M derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-13 | $9.20M derived: sum of 2 quarters · filed 2026-03-13 | $10.36M derived: sum of 3 quarters · filed 2026-03-13 | $11.94M 10-K · filed 2026-03-13 | |||||
| 2024-09-30 | $1.91M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-12 | $3.07M derived: sum of 2 quarters · filed 2025-11-12 | $4.65M 10-Q · filed 2025-11-12 | $4.56M derived: sum of 4 quarters · filed 2025-11-12 | |||||
| 2024-06-30 | $1.16M derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-14 | $2.74M 10-Q · filed 2025-08-14 | $2.65M derived: sum of 3 quarters · filed 2025-08-14 | $2.36M derived: sum of 4 quarters · filed 2025-08-14 | |||||
| 2024-03-31 | $1.58M 10-Q · filed 2025-05-15 | $1.49M derived: sum of 2 quarters · filed 2025-05-15 | $1.21M derived: sum of 3 quarters · filed 2025-05-15 | $923.09K derived: sum of 4 quarters · filed 2025-05-15 | |||||
| 2023-12-31 | -$93.50K derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-20 | -$376.51K derived: sum of 2 quarters · filed 2025-03-20 | -$659.52K derived: sum of 3 quarters · filed 2025-03-20 | $3.63M 10-K · filed 2025-03-20 | |||||
| 2023-09-30 | -$283.01K derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-13 | -$566.02K derived: sum of 2 quarters · filed 2024-11-13 | $3.73M 10-Q · filed 2024-11-13 | $2.00M derived: sum of 4 quarters · filed 2024-11-13 | |||||
| 2023-06-30 | -$283.01K derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-12 | $4.01M 10-Q · filed 2024-08-12 | $2.29M derived: sum of 3 quarters · filed 2024-08-12 | $3.31M derived: sum of 4 quarters · filed 2024-08-12 | |||||
| 2023-03-31 | $4.29M 10-Q · filed 2024-05-15 | $2.57M derived: sum of 2 quarters · filed 2024-05-15 | $3.59M derived: sum of 3 quarters · filed 2024-05-15 | $13.36M derived: sum of 4 quarters · filed 2024-05-15 | |||||
| 2022-12-31 | -$1.72M derived: 10-K 12 month − 10-Q 9 month · filed 2024-04-01 | -$703.00K derived: sum of 2 quarters · filed 2024-04-01 | $9.06M derived: sum of 3 quarters · filed 2024-04-01 | $9.06M 10-K · filed 2024-04-01 | |||||
| 2022-09-30 | $1.02M derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-13 | $10.79M derived: sum of 2 quarters · filed 2023-11-13 | $10.79M 10-Q · filed 2023-11-13 | $433.33K 10-Q · filed 2022-11-07 | |||||
| 2022-06-30 | $9.77M derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-14 | $9.77M 10-Q · filed 2023-08-14 | $0.00 10-Q · filed 2022-08-10 | ||||||
| 2022-03-31 | $0.00 10-Q · filed 2023-05-15 | ||||||||
| 2021-12-31 | $65.83M 10-K · filed 2022-03-31 | $1.23M 10-K · filed 2023-03-31 | |||||||
| 2021-09-30 | $9.86K 10-Q · filed 2022-11-07 | ||||||||
| 2021-06-30 | $34.25K 10-Q · filed 2022-08-10 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| VOLITIONRX LTD (VNRX) | $0.003B | -0.64 | |
| Q/C TECHNOLOGIES, INC. (QCLS) | United States | $0.008B | -1.93 |
| BIOMERICA INC (BMRA) | United States | $0.011B | |
| IMMUCELL CORP /DE/ (ICCC) | United States | $0.091B | 116.10 |
| Insight Molecular Diagnostics Inc. (IMDX) | United States | $0.129B | -3.90 |
| MYRIAD GENETICS INC (MYGN) | United States | $0.397B | -4.84 |
| Alpha Teknova, Inc. (TKNO) | United States | $0.500B | -18.12 |
| QuidelOrtho Corp (QDEL) | United States | $0.733B | -0.90 |
| ACHIEVE LIFE SCIENCES, INC. (ACHV) | United States | $0.806B | -5.88 |
| Intellia Therapeutics, Inc. (NTLA) | United States | $1.705B | -5.92 |